{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:59:23Z","timestamp":1792673963198,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1136\/ard.2009.125849","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T00:31:51Z","timestamp":1273105911000},"page":"1873-1879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Profound invariant natural killer T-cell deficiency in inflammatory arthritis"],"prefix":"10.1016","volume":"69","author":[{"given":"Susan J","family":"Tudhope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"von Delwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Falconer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Woolridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2009.125849_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1028","article-title":"Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity","volume":"3","author":"Wilson","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2009.125849_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri2451","article-title":"Harnessing invariant NKT cells in vaccination strategies","volume":"9","author":"Cerundolo","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2009.125849_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ard.2009.125849_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.21.120601.141057","article-title":"The regulatory role of Valpha14 NKT cells in innate and acquired immune response","volume":"21","author":"Taniguchi","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ard.2009.125849_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.coi.2003.09.014","article-title":"Natural killer T cells: natural or unnatural regulators of autoimmunity?","volume":"15","author":"Hammond","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1136\/ard.2009.125849_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.7538697","article-title":"CD1 recognition by mouse NK1+ T lymphocytes","volume":"268","author":"Bendelac","year":"1995","journal-title":"Science"},{"key":"10.1136\/ard.2009.125849_bib7","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"10.1136\/ard.2009.125849_bib8","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1084\/jem.188.8.1521","article-title":"CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution","volume":"188","author":"Brossay","year":"1998","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.125849_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.11489","article-title":"Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide","volume":"50","author":"Chiba","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.125849_bib10","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/art.22714","article-title":"Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis","volume":"56","author":"Kaieda","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.125849_bib11","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.4049\/jimmunol.179.4.2300","article-title":"A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner","volume":"179","author":"Coppieters","year":"2007","journal-title":"J Immunol"},{"key":"10.1136\/ard.2009.125849_bib12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20011908","article-title":"Distinct functional lineages of human V(alpha)24 natural killer T cells","volume":"195","author":"Lee","year":"2002","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.125849_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02647.x","article-title":"Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11","volume":"122","author":"Montoya","year":"2007","journal-title":"Immunology"},{"key":"10.1136\/ard.2009.125849_bib14","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W","article-title":"Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases","volume":"44","author":"Kojo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.125849_bib15","doi-asserted-by":"crossref","first-page":"R493","DOI":"10.1186\/ar1695","article-title":"Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis","volume":"7","author":"Linsen","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2009.125849_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/clim.2001.5060","article-title":"Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage","volume":"100","author":"van der Vliet","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1136\/ard.2009.125849_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/rheumatology\/kel437","article-title":"NKT cells: manipulable managers of joint inflammation","volume":"46","author":"Coppieters","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.125849_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20041400","article-title":"NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production","volume":"201","author":"Kim","year":"2005","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.125849_bib19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/eji.200323707","article-title":"Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment","volume":"33","author":"Sandberg","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2009.125849_bib20","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/JVI.77.3.2251-2257.2003","article-title":"Frequency and phenotype of circulating Valpha24\/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection","volume":"77","author":"Lucas","year":"2003","journal-title":"J Virol"},{"key":"10.1136\/ard.2009.125849_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI0213605","article-title":"Multiple immuno-regulatory defects in type-1 diabetes","volume":"109","author":"Kukreja","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2009.125849_bib22","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.4049\/jimmunol.168.11.5514","article-title":"Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes","volume":"168","author":"Gadola","year":"2002","journal-title":"J Immunol"},{"key":"10.1136\/ard.2009.125849_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1172\/JCI0215832","article-title":"Testing the NKT cell hypothesis of human IDDM pathogenesis","volume":"110","author":"Lee","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2009.125849_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/intimm\/dxg029","article-title":"Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission","volume":"15","author":"Araki","year":"2003","journal-title":"Int Immunol"},{"key":"10.1136\/ard.2009.125849_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1084\/jem.193.8.893","article-title":"The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families","volume":"193","author":"Park","year":"2001","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.125849_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what's in a name?","volume":"4","author":"Godfrey","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2009.125849_bib27","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20051381","article-title":"A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance","volume":"202","author":"Terabe","year":"2005","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.125849_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10522-006-9063-5","article-title":"Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly","volume":"7","author":"Peralbo","year":"2006","journal-title":"Biogerontology"},{"key":"10.1136\/ard.2009.125849_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.exger.2007.01.009","article-title":"Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood","volume":"42","author":"Jing","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1136\/ard.2009.125849_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ijc.20998","article-title":"Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load","volume":"116","author":"Molling","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1136\/ard.2009.125849_bib31","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/art.23078","article-title":"Histopathologic changes at \u201csynovio-entheseal complexes\u201d suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis","volume":"56","author":"Benjamin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.125849_bib32","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/art.11094","article-title":"Inflammation and angiogenesis in osteoarthritis","volume":"48","author":"Haywood","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.125849_bib33","first-page":"689","article-title":"Inflammation as an important feature of osteoarthritis","volume":"81","author":"Brooks","year":"2003","journal-title":"Bull WHO"},{"key":"10.1136\/ard.2009.125849_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clim.2009.11.007","article-title":"Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis","volume":"134","author":"Parietti","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1136\/ard.2009.125849_bib35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.20011786","article-title":"Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining","volume":"195","author":"Gumperz","year":"2002","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2009.125849_bib36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20061551","article-title":"Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia","volume":"204","author":"Michel","year":"2007","journal-title":"J Exp Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724148352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724148352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2009.125849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T11:32:42Z","timestamp":1736076762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724148352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0003496724148352"],"URL":"https:\/\/doi.org\/10.1136\/ard.2009.125849","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profound invariant natural killer T-cell deficiency in inflammatory arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2009.125849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/group.bmj.com\/group\/rights-licensing\/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}